Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (309)
- Scheduling (national classification system) (165)
- Advertising (25)
- Safety monitoring and information (23)
- COVID-19 (11)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Clinical trials (4)
- Compliance and enforcement (4)
- Shortages and supply disruptions (3)
- Legislation (2)
- Breast implant hub (1)
- Cosmetics (1)
- Import and export (1)
- Manufacturing (1)
- Prescription opioids hub (1)
Search
580 result(s) found, displaying 401 to 425
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS/ACCS meetings held in November 2018
-
Scheduling decisions (final)Final decisions and reasons for NCEs and medicines and chemicals referred to the November 2018 scheduling meetings (ACMS #25, ACCS #23 and Joint ACMS-ACCS #20).
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 28 March 2019
-
Meeting statementsCommunique from the second meeting of the TGACC
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
Meeting statementsThe Public Statement for the Generic Medicines Working Group face-to-face meeting in Canberra, October 2018
-
Corporate reportsThe Action Plan will further improve Australia’s medical device regulatory system and place patient safety first
-
Meeting statementsPublic statement for the Generic Medicines Working Group face-to-face meeting in Switzerland, May 2018
-
Meeting statementsCommunique summarising outcomes of the alkyl nitrites public meetings in Sydney and Melbourne
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
TGA laboratory testing reportsThe TGA has tested a range of human insulin products and all met the applicable quality standards
-
Corporate reports
-
Meeting statementsACM 12 meeting statement has been published
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 7 March 2019
-
Corporate reportsAlkyl nitrites public meeting questions and answers are now available
-
Scheduling submissionsThe TGA would like to thank respondents who provided submissions in response to the November 2018 public consultation paper
-
Meeting statementsCommunique from the first meeting of the TGACC
-
Corporate reports
-
Corporate reportsThe TGA conducted a survey of Australian adults in June and July 2018
-
Corporate reports2018 TGA stakeholder survey reports available
-
Scheduling submissionsPublic submissions on the delegate's interim decisions
-
Scheduling decisions (final)Delegate only final scheduling decisions on NCEs and Appendix H are now available
-
Scheduling decisions (final)Final decisions and reasons for medicines and chemicals referred to the June 2018 scheduling meetings (ACMS #24 and Joint ACMS-ACCS #19) and delegate-only decisions on agricultural and veterinary chemicals.
-
Meeting statementsThe Advisory Committee on Medicines meeting statement for Meeting 11 is now available
-
Corporate reportsOverview of what we have done in response to comments in the 2017 TGA stakeholder survey.